Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. 552-22-7
2. Iodothymol
3. Iodistol
4. Iodohydromol
5. Annidalin
6. Aristol
7. Iodosol
8. Iothymol
9. Lothymol
10. Thymiode
11. Thymiodol
12. Thymodin
13. Thymotol
14. Iosol
15. Thymoliodide
16. [4-(4-iodooxy-2-methyl-5-propan-2-ylphenyl)-5-methyl-2-propan-2-ylphenyl] Hypoiodite
17. A51hjm3xsu
18. 5,5'-diisopropyl-2,2'-dimethylbiphenyl-4,4'-diyl Dihypoiodite
19. Nsc-2222
20. Ncgc00159504-02
21. 1,1'-biphenyl, 4,4'-bis(iodooxy)-2,2'-dimethyl-5, 5'-bis(1-methylethyl)-
22. 4,4'-bis(iodooxy)-2,2'-dimethyl-5,5'-bis(1-methylethyl-1,1'-biphenyl
23. Dsstox_cid_26081
24. Dsstox_rid_81323
25. Dsstox_gsid_46081
26. Diiododithymol
27. Bithymol Diiodide
28. Dithymol Diiodide
29. Cas-552-22-7
30. Iodothymol (van)
31. Thymol Iodide [nf]
32. Unii-a51hjm3xsu
33. Thymol-iodide
34. Hsdb 867
35. Nsc 2222
36. Einecs 209-007-5
37. Thymol Iodide [hsdb]
38. Schembl467308
39. Thymol Iodide [vandf]
40. Thymol Iodide [who-dd]
41. Chembl1482931
42. Dtxsid3046081
43. Nsc2222
44. Hy-b1796
45. Zinc4217551
46. Tox21_111723
47. Akos024319269
48. Tox21_111723_1
49. 4,4'-bis(i4,4'-bodooxy)-2,2'-dimethyl-5,5'-bis(1-methylethyl-1,1'-biphenyl
50. Hypoiodous Acid, 2,2'-dimethyl-5,5'-bis(1-methylethyl)(1,1'-biphenyl)-4,4'-diyl Ester
51. Ncgc00159504-03
52. Ncgc00159504-04
53. Thymol Iodide Or Dithymol Diiodide
54. Bs-28664
55. Cs-0013832
56. Sr-01000883682
57. Sr-01000883682-1
58. Q27273640
59. 1, 4,4'-bis(iodooxy)-2,2'-dimethyl-5,5'-bis(1-methylethyl)-
60. 4'-(iodooxy)-2,2'-dimethyl-5,5'-bis(propan-2-yl)-[1,1'-biphenyl]-4-yl Hypoiodite
61. Hypoiodous Acid,2'-dimethyl-5,5'-bis(1-methylethyl)[1,1'-biphenyl]-4,4'-diyl Ester
62. Hypoiodous Acid, I,i'-(2,2'-dimethyl-5,5'-bis(1-methylethyl)(1,1'-biphenyl)-4,4'-diyl) Ester
| Molecular Weight | 550.2 g/mol |
|---|---|
| Molecular Formula | C20H24I2O2 |
| XLogP3 | 8.2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 3 |
| Exact Mass | 549.98658 g/mol |
| Monoisotopic Mass | 549.98658 g/mol |
| Topological Polar Surface Area | 18.5 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 352 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
3. 3= MODERATELY TOXIC: PROBABLE ORAL LETHAL DOSE (HUMAN), BETWEEN 1 OUNCE & 1 PINT (OR 1 LB) FOR 70 KG PERSON (150 LB). /IODIDE SALTS/
Gosselin, R.E., H.C. Hodge, R.P. Smith, and M.N. Gleason. Clinical Toxicology of Commercial Products. 4th ed. Baltimore: Williams and Wilkins, 1976., p. II-78
ABOUT THIS PAGE
91
PharmaCompass offers a list of Thymol Iodide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Thymol Iodide manufacturer or Thymol Iodide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Thymol Iodide manufacturer or Thymol Iodide supplier.
A Thymodin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Thymodin, including repackagers and relabelers. The FDA regulates Thymodin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Thymodin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Thymodin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Thymodin supplier is an individual or a company that provides Thymodin active pharmaceutical ingredient (API) or Thymodin finished formulations upon request. The Thymodin suppliers may include Thymodin API manufacturers, exporters, distributors and traders.
click here to find a list of Thymodin suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Thymodin written confirmation (Thymodin WC) is an official document issued by a regulatory agency to a Thymodin manufacturer, verifying that the manufacturing facility of a Thymodin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Thymodin APIs or Thymodin finished pharmaceutical products to another nation, regulatory agencies frequently require a Thymodin WC (written confirmation) as part of the regulatory process.
click here to find a list of Thymodin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Thymodin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Thymodin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Thymodin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Thymodin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Thymodin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Thymodin suppliers with NDC on PharmaCompass.
Thymodin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Thymodin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Thymodin GMP manufacturer or Thymodin GMP API supplier for your needs.
A Thymodin CoA (Certificate of Analysis) is a formal document that attests to Thymodin's compliance with Thymodin specifications and serves as a tool for batch-level quality control.
Thymodin CoA mostly includes findings from lab analyses of a specific batch. For each Thymodin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Thymodin may be tested according to a variety of international standards, such as European Pharmacopoeia (Thymodin EP), Thymodin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Thymodin USP).